PCG
Prosperity Consulting Group’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $363K | Sell |
7,838
-361
| -4% | -$16.7K | 0.03% | 347 |
|
|
2025
Q1 | $500K | Sell |
8,199
-2,286
| -22% | -$139K | 0.04% | 303 |
|
|
2024
Q4 | $593K | Sell |
10,485
-925
| -8% | -$52.3K | 0.04% | 290 |
|
|
2024
Q3 | $590K | Buy |
11,410
+3,224
| +39% | +$167K | 0.05% | 295 |
|
|
2024
Q2 | $340K | Sell |
8,186
-2,593
| -24% | -$108K | 0.05% | 239 |
|
|
2024
Q1 | $585K | Buy |
10,779
+1,049
| +11% | +$56.9K | 0.07% | 176 |
|
|
2023
Q4 | $499K | Sell |
9,730
-403
| -4% | -$20.7K | 0.17% | 107 |
|
|
2023
Q3 | $588K | Buy |
10,133
+835
| +9% | +$48.5K | 0.27% | 81 |
|
|
2023
Q2 | $595K | Sell |
9,298
-929
| -9% | -$59.4K | 0.37% | 61 |
|
|
2023
Q1 | $709K | Sell |
10,227
-8,739
| -46% | -$606K | 0.45% | 53 |
|
|
2022
Q4 | $1.36M | Buy |
18,966
+35
| +0.2% | +$2.52K | 0.91% | 32 |
|
|
2022
Q3 | $1.35M | Sell |
18,931
-533
| -3% | -$37.9K | 1.1% | 26 |
|
|
2022
Q2 | $1.5M | Sell |
19,464
-725
| -4% | -$55.8K | 1.3% | 26 |
|
|
2022
Q1 | $1.47M | Sell |
20,189
-460
| -2% | -$33.6K | 1.09% | 26 |
|
|
2021
Q4 | $1.34M | Buy |
+20,649
| New | +$1.34M | 1% | 27 |
|